Medicines that might be eliminated cover therapeutic areas such as cardiovascular disease, digestive problems, cancer, diseases of the central nervous system, and respiratory disease.
The association expects the clawback tax, a tax on turnover for medicines manufacturers, will reach 30% by the end of the year.
Grecu said the clawback is expected to reach 30% by the end of the year, spelling difficulty for all generics manufacturers, particularly local ones.
“An annual clawback of 30% means the pharmaceutical industry, manufacturers, contribute RON2.6 billion to finance medicines in Romania,” he said.